Hereditary Testing Market Size Worth USD 17.13 Billion by 2034 | CAGR: 8.3%

Hereditary Testing Market Size Worth USD 17.13 Billion by 2034 | CAGR: 8.3%


The hereditary testing market size is expected to reach USD 17.13 billion by 2034, according to a new study by Polaris Market Research. The report “Hereditary Testing Market Size, Share, Trends, Industry Analysis Report: By Technology (Cytogenetic, Biochemical, and Molecular Testing), Sample Type, Disease Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Hereditary testing is a genetic diagnostic procedure used to identify inherited mutations that may contribute to disease development. It enables early detection, risk assessment, and personalized treatment planning. The hereditary testing market is experiencing significant growth due to advancements in next-generation sequencing, increasing awareness of genetic disorders, and rising demand for precision medicine.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/hereditary-testing-market/request-for-customization

Opportunities in the market are expanding with the integration of artificial intelligence for improved genetic analysis and the growing adoption of direct-to-consumer genetic testing. Key trends include the increasing focus on hereditary cancer testing, the expansion of noninvasive prenatal testing, and regulatory developments supporting hereditary testing market expansion. Rising healthcare expenditures, improved accessibility to genetic testing, and the global emphasis on preventive healthcare solutions further drive the market.

Hereditary Testing Market Report Highlights

  • Molecular testing held the largest hereditary testing market share in 2024 due to its high accuracy and widespread adoption in genetic analysis.
  • The blood segment dominated the market as it is widely used for genetic testing due to its ease of collection and reliability. Saliva-based testing is witnessing the fastest growth due to the increasing demand for non-invasive and at-home genetic testing solutions.
  • North America dominated the hereditary testing market in 2024 due to well-established healthcare infrastructure, strong regulatory frameworks, and high adoption of genetic testing. Asia Pacific is the fastest-growing region, driven by increasing healthcare investments, rising awareness of genetic disorders, and expanding genetic testing services in emerging economies.
  • Some of the major players in the market include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., Illumina, Inc., Laboratory Corporation of America Holdings, MedGenome Inc., Myriad Genetics, Inc., Natera, Inc., Quest Diagnostics Incorporated, SOPHiA GENETICS SA, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, WuXi NextCODE Genomics, Inc.

Polaris Market Research has segmented hereditary testing market report on basis of technology, sample type, disease type, and region:

By Technology Outlook (Revenue-USD Billion, 20202034)

  • Cytogenetic
  • Biochemical
  • Molecular Testing

By Sample Type Outlook (Revenue-USD Billion, 20202034)

  • Tumor Tissue
  • Bone Marrow
  • Saliva
  • Blood
  • Others

By Disease Type Outlook (Revenue-USD Billion, 20202034)

  • Hereditary Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Breast Cancer
  • Melanoma
  • Sarcoma
  • Others

By Regional Outlook (Revenue-USD Billion, 20202034)

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Netherlands
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Malaysia
    • South Korea
    • Indonesia
    • Australia
    • Vietnam
    • Rest of Asia Pacific
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Israel
    • South Africa
    • Rest of Middle East & Africa
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America

Hereditary Testing Market Report Scope

Report Attributes

Details

Market Size Value in 2024

USD 7.73 billion

Market Size Value in 2025

USD 8.36 billion

Revenue Forecast by 2034

USD 17.13 billion

CAGR

8.3% from 2025 to 2034

Base Year

2024

Historical Data

2020–2023

Forecast Period

2025–2034

Quantitative Units

Revenue in USD billion and CAGR from 2025 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Industry Trends

Segments Covered

  • By Technology
  • By Sample Type
  • By Disease Type

Regional Scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Hereditary Testing Market Share Analysis (2024)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

For Specific Research Requirements Request for Customized Report

License and Pricing

Purchase Report Sections

  • Regional analysis
  • Segmentation analysis
  • Industry outlook
  • Competitive landscape
Request for Discount Pricing

Connect with experts